Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.60 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propanil SCHEMBL26871 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHREPHX1EPHX2ALDH1A1 | |
| Propanil SCHEMBL21900164 | 1.00 | CYP3A4 (1.00) | CYP3A4TSHREPHX1EPHX2ALDH1A1 | |
| Propanil SCHEMBL8983219 | 0.98 | CYP3A4 (0.96) | CYP3A4TSHREPHX1EPHX2ALDH1A1 | |
| Propanil SCHEMBL634840 | 0.98 | CYP3A4 (0.96) | CYP3A4TSHREPHX1EPHX2ALDH1A1 | |
| Propanil SCHEMBL19358624 | 0.91 | CYP3A4 (0.82) | CYP3A4TSHREPHX1EPHX2ALDH1A1 | |
| SCHEMBL11865051 | 0.87 | CYP3A4 (0.75) | CYP3A4TSHRALDH1A1KMT2AMEN1 | |
| SCHEMBL14426539 | 0.86 | CYP3A4 (0.75) | CYP3A4TSHRALDH1A1KMT2AMEN1 | |
| SCHEMBL3674141 | 0.86 | CYP3A4 (0.75) | CYP3A4EPHX1EPHX2ALDH1A1KMT2A | |
| SCHEMBL12796807 | 0.86 | CYP3A4 (0.75) | CYP3A4TSHREPHX2ALDH1A1KMT2A | |
| SCHEMBL15302068 | 0.84 | TSHR (1.00) | CYP3A4TSHRALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10689328-B2 | Crystalline modification of propanil | UPL LIMITED (IN) | 2020-06-23 | — | — | US | disclosed |
| US-20190248734-A1 | CRYSTALLINE MODIFICATION OF PROPANIL | UPL LIMITED | 2019-08-15 | — | — | US | disclosed |
| US-10336685-B2 | Crystalline modification of propanil | UPL LIMITED (IN) | 2019-07-02 | — | — | US | disclosed |
| US-20170369423-A1 | CRYSTALLINE MODIFICATION OF PROPANIL | UPL LIMITED (IN) | 2017-12-28 | — | — | US | disclosed |
| EP-3247698-A1 | CRYSTALLINE MODIFICATION OF PROPANIL | UPL Limited (IN) | 2017-11-29 | — | — | EP | disclosed |
| WO-2016116797-A1 | CRYSTALLINE MODIFICATION OF PROPANIL | UPL LIMITED (IN) | 2016-07-28 | — | — | WO | disclosed |
| EP-2701747-A2 | HSP90 COMBINATION THERAPY | Sloan-Kettering Institute for Cancer Research (US) | 2014-03-05 | — | — | EP | disclosed |
| US-20130210630-A1 | SELF-EMULSIFYING OIL | ISP INVESTMENTS INC. (DE) | 2013-08-15 | — | — | US | disclosed |
| WO-2012149493-A2 | HSP90 COMBINATION THERAPY | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012003441-A1 | SELF-EMULSIFYING OIL | ISP INVESTMENTS INC. (US) | 2012-01-05 | — | — | WO | disclosed |
| US-5250499-A | Delivery system for agricultural chemicals | ISP INVESTMENTS INC. (US) | 1993-10-05 | — | — | US | disclosed |
| US-5176736-A | Emulsifiable herbicide concentrate | ISP INVESTMENTS INC. (US) | 1993-01-05 | — | — | US | disclosed |
| US-5160528-A | Stable emulsifiable herbicide concentrates | ISP INVESTMENTS INC. (US) | 1992-11-03 | — | — | US | disclosed |
| US-5156666-A | Emulsifiable concentrate comprising a pesticide, a surfactant, a hydrophobic solvent and a hydrophilic solvent; storage stability | ISP INVESTMENTS INC. (US) | 1992-10-20 | — | — | US | disclosed |
| EP-0505378-A1 | DELIVERY SYSTEM FOR AGRICULTURAL CHEMICALS | ISP INVESTMENTS INC. (US) | 1992-09-30 | — | — | EP | disclosed |
| WO-1992013845-A1 | ARYL SULPHONYL UREA COMPOUNDS, A METHOD OF PREPARING THEM, AND THEIR USE AS HERBICIDES AND GROWTH REGULATORS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-08-20 | — | — | WO | disclosed |
| WO-1992004827-A1 | HERBICIDAL SUBSTITUTED BICYCLIC TRIAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-02 | — | — | WO | disclosed |
| US-5071463-A | Stable, emulsifiable concentrate of an herbicide and pyrrolido ne derivative; dispersibility | ISP INVESTMENTS INC. (US) | 1991-12-10 | — | — | US | disclosed |
| WO-1990012012-A1 | SUBSTITUTED PHENYLTRIAZOLOPYRIMIDINE HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-18 | — | — | WO | disclosed |
| EP-0019796-A1 | Propionic acid esters, preparation of these compounds, herbicides containing these compounds as active substances, and the use of such compounds and agents for combating weeds | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1980-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210630-A1 | SELF-EMULSIFYING OIL | PHOSPHO1, SQLE, ALOX15 | CYP3A4 3856/4885TSHR 4755/4885EPHX1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.